the market?
ISIS Pharmaceuticals, Inc.
NASDAQ: ISIS
20.98
0.34
(1.65%)
| Today's Open | $20.55 |
|---|---|
| Previous Close | $20.64 |
| Daily Range | $20.43 - $21.07 |
| 52-Week Range | $7.56 - $23.03 |
| Market Cap | $2.2B |
| P/E Ratio | -48.00 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 878,047 |
| Average Daily Volume | 1,779,950 |
| Current FY EPS | -$0.79 |
How do you think ISIS
will perform against the market?
Top ISIS Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
August 7, 2010
Isis, like many small biotechs and pharmas, can be looked at as a microcosm of the stock market as a whole. There's always a bull case and a bear case, but baby biotechs rarely follow a straight traje … More
News & Commentary
Presentation Pandemonium = 30% Pop
Why shares of Aegerion soared more than 30% today.1 Biotech's Surprise Dilution Decoded
Isis Pharmaceuticals gives biotech investors a painful reminder that dilution can come when they least expect it.3 Horrendous Health-Care Stocks This Week
These three health-care stocks were party-poopers this week as investors celebrated the market hitting all-time highs, yet again.3 Investment Ideas for Biotech Investors
Early disruptive technology.What News Will Drive Amgen Stock Next?
As a big biotech, Amgen is driven by sales and pipeline news.2 Orphan Drugmakers With Upcoming Catalysts
Shares for these 2 orphan drugmakers will either soar or sink in a few days. Here's why.Best Stocks: Biotech Still Holding Top Spots
Biotech remains at the top of his week's "10.0 report" with three new buy ratings.Sector
Healthcare
Industry
Drugs
ISIS Pharmaceuticals, Inc. (ISIS) Description
The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/
CEO Rating by Glassdoor
More details for Isis Pharmaceuticals Jobs
Isis Pharmaceuticals reviews from employees
